Tesamorelin

Modified GHRH analog (N-terminal acyl group), 10mg vial

$139.00

Format Lyophilized powder, vial

Purity ≥99% (HPLC)

CAS 218949-48-5

Documentation COA by request

This product is intended for in-vitro and pre-clinical research purposes only. It is not intended for human consumption, nor for use as a drug, food additive, or household chemical. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer acknowledges all risks of handling and distribution, and agrees to indemnify Sokai Sciences against any claims arising from misuse.

FAQ

Common questions

What is Tesamorelin?+

A synthetic GHRH analog with an N-terminal trans-3-hexenoic acid modification.

What does that N-terminal modification do?+

It's studied in the literature for extending resistance to enzymatic breakdown relative to the unmodified hormone.

What CAS number identifies Tesamorelin?+

218949-48-5.

About

About Tesamorelin

Tesamorelin is a synthetic analog of growth-hormone-releasing hormone (GHRH), structurally modified with a trans-3-hexenoic acid group at the N-terminus, studied in the literature for resisting enzymatic degradation relative to native GHRH. Synthesized to ≥99% purity (HPLC); certificate of analysis available per batch. For laboratory research use only.

You may also want

#gh-axis CJC-1295 (With DAC) Sold out

GH Axis

DAC-modified GHRH analog, 2mg vial

Lyophilized powder, vial · 3 sizes

#gh-axis CJC-1295 (Without DAC) Sold out

GH Axis

GHRH analog (Mod GRF 1-29), 2mg vial

Lyophilized powder, vial · 3 sizes

#gh-axis CJC-1295 / Ipamorelin (Blend)

GH Axis

GHRH analog + selective GH secretagogue blend

Lyophilized powder, vial · 2 sizes